These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36971659)

  • 1. Identification and Characterization of chCR2, a Protein That Binds Chicken Complement Component 3d.
    Jin H; Kong Z; Jiang B; Tu M; Xu J; Cheng J; Liu W; Zhang Z; Li Y
    J Immunol; 2023 May; 210(9):1408-1418. PubMed ID: 36971659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and structural analysis of dimeric chicken complement component 3d and its binding with chicken complement receptor 2.
    Jin H; Tu M; Meng Z; Jiang B; Yang Q; Li Y; Zhang Z
    Dev Comp Immunol; 2024 Mar; 152():105109. PubMed ID: 38061436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of the C3d ligand binding site on complement receptor 2 (CR2/CD21) using nuclear magnetic resonance and chemical shift analysis.
    Kovacs JM; Hannan JP; Eisenmesser EZ; Holers VM
    J Biol Chem; 2009 Apr; 284(14):9513-20. PubMed ID: 19164292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
    Guthridge JM; Young K; Gipson MG; Sarrias MR; Szakonyi G; Chen XS; Malaspina A; Donoghue E; James JA; Lambris JD; Moir SA; Perkins SJ; Holers VM
    J Immunol; 2001 Nov; 167(10):5758-66. PubMed ID: 11698449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
    Carel JC; Myones BL; Frazier B; Holers VM
    J Biol Chem; 1990 Jul; 265(21):12293-9. PubMed ID: 1695627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
    Hannan JP; Young KA; Guthridge JM; Asokan R; Szakonyi G; Chen XS; Holers VM
    J Mol Biol; 2005 Feb; 346(3):845-58. PubMed ID: 15713467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.
    Shaw CD; Storek MJ; Young KA; Kovacs JM; Thurman JM; Holers VM; Hannan JP
    J Mol Biol; 2010 Dec; 404(4):697-710. PubMed ID: 20951140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.
    Kovacs JM; Hannan JP; Eisenmesser EZ; Holers VM
    J Biol Chem; 2010 Aug; 285(35):27251-27258. PubMed ID: 20558730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided identification of C3d residues essential for its binding to complement receptor 2 (CD21).
    Clemenza L; Isenman DE
    J Immunol; 2000 Oct; 165(7):3839-48. PubMed ID: 11034390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The electrostatic nature of C3d-complement receptor 2 association.
    Morikis D; Lambris JD
    J Immunol; 2004 Jun; 172(12):7537-47. PubMed ID: 15187133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure.
    Isenman DE; Leung E; Mackay JD; Bagby S; van den Elsen JM
    J Immunol; 2010 Feb; 184(4):1946-55. PubMed ID: 20083651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
    Guthridge JM; Rakstang JK; Young KA; Hinshelwood J; Aslam M; Robertson A; Gipson MG; Sarrias MR; Moore WT; Meagher M; Karp D; Lambris JD; Perkins SJ; Holers VM
    Biochemistry; 2001 May; 40(20):5931-41. PubMed ID: 11352728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A theoretical view of the C3d:CR2 binding controversy.
    Mohan RR; Gorham RD; Morikis D
    Mol Immunol; 2015 Mar; 64(1):112-22. PubMed ID: 25433434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
    Molina H; Kinoshita T; Webster CB; Holers VM
    J Immunol; 1994 Jul; 153(2):789-95. PubMed ID: 8021513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H; Brenner C; Jacobi S; Gorka J; Carel JC; Kinoshita T; Holers VM
    J Biol Chem; 1991 Jul; 266(19):12173-9. PubMed ID: 1712014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular mechanism of pH-regulating C3d-CR2 interactions: Insights from molecular dynamics simulation.
    Zhang Y; Guo J; Ning L; Tian J; Yao X; Liu H
    Chem Biol Drug Des; 2019 Apr; 93(4):628-637. PubMed ID: 30566277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
    Asokan R; Hua J; Young KA; Gould HJ; Hannan JP; Kraus DM; Szakonyi G; Grundy GJ; Chen XS; Crow MK; Holers VM
    J Immunol; 2006 Jul; 177(1):383-94. PubMed ID: 16785534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d.
    Wan H; Hu JP; Tian XH; Chang S
    Phys Chem Chem Phys; 2013 Jan; 15(4):1241-51. PubMed ID: 23229122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and structural analysis of complement component 3d in wild birds provides insight into its functional evolution.
    Jiang B; Zhang Z; Xu J; Jin H; Tuya ; Li Y
    Dev Comp Immunol; 2021 Apr; 117():103979. PubMed ID: 33338517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.